Cargando…
Fidaxomicin jams Mycobacterium tuberculosis RNA polymerase motions needed for initiation via RbpA contacts
Fidaxomicin (Fdx) is an antimicrobial RNA polymerase (RNAP) inhibitor highly effective against Mycobacterium tuberculosis RNAP in vitro, but clinical use of Fdx is limited to treating Clostridium difficile intestinal infections due to poor absorption. To identify the structural determinants of Fdx b...
Autores principales: | Boyaci, Hande, Chen, James, Lilic, Mirjana, Palka, Margaret, Mooney, Rachel Anne, Landick, Robert, Darst, Seth A, Campbell, Elizabeth A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837556/ https://www.ncbi.nlm.nih.gov/pubmed/29480804 http://dx.doi.org/10.7554/eLife.34823 |
Ejemplares similares
-
Molecular dissection of RbpA-mediated regulation of fidaxomicin sensitivity in mycobacteria
por: Prusa, Jerome, et al.
Publicado: (2022) -
Co-evolution of RNA polymerase with RbpA in the phylum Actinobacteria
por: Dey, Abhinav, et al.
Publicado: (2012) -
Structure and function of the mycobacterial transcription initiation complex with the essential regulator RbpA
por: Hubin, Elizabeth A, et al.
Publicado: (2017) -
RbpA relaxes promoter selectivity of M. tuberculosis RNA polymerase
por: Sudalaiyadum Perumal, Ayyappasamy, et al.
Publicado: (2018) -
Mycobacterium RbpA cooperates with the stress-response σ(B) subunit of RNA polymerase in promoter DNA unwinding
por: Hu, Yangbo, et al.
Publicado: (2014)